medigraphic.com
ISSN 2992-8559 (Electronic)
ISSN 1405-0625 (Print)

2021, Number 1

<< Back Next >>

Cir Plast 2021; 31 (1)

Leg seroma due to calf implants

Arceo-Giorgana L, Cuenca-Pardo JA, Niño R

Language: Spanish
References: 55
Page: 31-38
PDF size: 413.10 Kb.


ABSTRACT

Seroma is an eventuality that can occur in patients with breast implants. It can be produced by different etiologies and it is a warning of mammary pathologies related to mammary implants. The study of the periprosthetic liquid is necessary to identify the cause and give an adequate treatment. We were not able to find reports in the medical literature of seroma in the legs due to calf implants. We present a case of a 59-year-old patient with 28-year-old leg implants. She had seroma of four years of evolution. Prior to surgery the volume increased considerably, the implant was removed, the fluid evacuated and the capsule resected. We found the implant was broken and it had intracapsular silicone leak. The specimens were sent to pathology and to the laboratory for their study. The report mentioned a xanthogranulomatous reaction, with response to a foreign body. In cultures, including for mycobacteria, there was no development. The findings during surgery and the pathology report help us to deduce that the implant rupture and the silicone gel leak were the cause of the seroma. The breakage and leakage of silicone is attributable to the length of time in the patient, to the effects of degradation and the sports practiced by the patient.


REFERENCES

  1. Lista F, Ahmad J. Evidence-based medicine: augmentation mammaplasty. Plast Reconstr Surg 2013; 132 (6): 1684-1696.

  2. Ronchi A, Montella M, Argenzio V, Lucia A, De Renzo A, Alfano R et al. Diagnosis of anaplastic large cell lymphoma on late peri-implant breast seroma: management of cytological sample by an integrated approach. Cytopathology 2018; 29 (3): 294-299.

  3. Derby BM, Codner MA. Textured silicone breast implant use in primary augmentation: core data update and review. Plast Reconstr Surg 2015; 135: 113-124.

  4. Lista F, Tutino R, Khan A, Ahmad J. Subglandular breast augmentation with textured, anatomic, cohesive silicone implants: a review of 440 consecutive patients. Plast Reconstr Surg 2013; 132 (2): 295-302.

  5. Bengtson B, Brody GS, Brown MH, Glicksman C, Hammond D, Kaplan H et al. Managing late periprosthetic fluid collections (seroma) in patients with breast implants: a consensus panel recommendation and review of the literature. Plast Reconstr Surg 2011; 128 (1): 1-7.

  6. Jordan SW, Khavanin N, Kim JYS. Seroma in prosthetic breast reconstruction. Plast Reconstr Surg 2016; 137 (4): 1104-1116.

  7. Brohim RM, Foresman PA, Hildebrandt PK, Rodeheaver GT. Early tissue reaction to textured breast implants surfaces. Ann Plast Surg 1992; 28: 354-362.

  8. Malata CM, Feldberg L, Coleman DJ, Foo IT, Sharpe DT. Textured or smooth implants for breast augmentation? Three year follow-up of a prospective randomized controlled trial. Br J Plast Surg 1997; 50: 99-105.

  9. Coleman DJ, Foo IT, Sharpe DT. Textured or smooth implants for breast augmentation? A prospective controlled trial. Br J Plast Surg 1991; 44: 444-448.

  10. Collis N, Coleman D, Foo IT, Sharpe DT. Ten-year review of a prospective randomized controlled trial of textured versus smooth subglandular silicone gel breast implants. Plast Reconstr Surg 2000; 106: 786-791.

  11. Hall-Findlay EJ. Breast implant complication review: double capsules and late seromas. Plast Reconstr Surg 2011; 127: 56-66.

  12. Spear SL, Rottman SJ, Glicksman C, Brown M, Al-Attar A. Late seromas after breast implants: Theory and practice. Plast Reconstr Surg 2012; 130: 423-435.

  13. Bengtson B, Brody GS, Brown MH, Glicksman C, Hammond D, Kaplan H et al. Late periprosthetic fluid collection after breast implant working group. Managing late periprosthetic fluid collections (seroma) in patients with breast implants: A consensus panel recommendation and review of the literature. Plast Reconstr Surg 2011; 128: 1-7.

  14. Santanelli di Pompeo F, Laporta R, Sorotos M, Di Napoli A, Giovagnoli MR, Cox MC et al. Breast implant–associated anaplastic large cell lymphoma: Proposal for a monitoring protocol. Plast Reconstr Surg 2015; 136: 144e-151e.

  15. Di Napoli A. Achieving reliable diagnosis in late breast implant seromas: from reactive to anaplastic large cell lymphoma. Plast Reconstr Surg 2019; 143: 15S-22S.

  16. Becker H, Klimczak J. Aspiration of periprosthetic seromas using the blunt seroma cath. Plast Reconstr Surg 2016; 137 (2): 473-475.

  17. Chourmouzi D, Vryzas T, Drevelegas A. New spontaneous breast seroma 5 years after augmentation: a case report. Cases J 2009; 2: 7126.

  18. Fodor L, Moscona R. Late post-traumatic intracapsular seroma after breast augmentation. J Plast Reconstr Aesthet Surg 2009; 62: e609-e610.

  19. Hasham S, Akhtar S, Fourie LR. Persistent seroma following breast prosthesis explantation: A case report and review. Eur J Plast Surg 2006; 28: 490-493.

  20. Mazzocchi M, Dessy LA, Carlesimo B, Marchetti F, Scuderi N. Late seroma formation after breast surgery with textured silicone implants: a problem worth bearing in mind. Plast Reconstr Surg 2010; 125: 176e-177e.

  21. Mazzochi M, Dessy LA, Corrias F, Scuderi N. A clinical study of late seroma in breast implantation surgery. Aesthet Plast Surg 2012; 36 (1): 97-104.

  22. Oliveira VM, Roveda Junior D, Lucas FB, Lucarelli AP, Martins MM, Rinaldi JF et al. Late seroma after breast augmentation with silicone prostheses: a case report. Breast J 2007; 13: 421-423.

  23. Tansley PD, Powell BW. Late swelling after bilateral breast augmentation. J Plast Reconstr Aesthet Surg 2011; 64: 261-263.

  24. Pinchuk V, Tymofii O. Seroma as a late complication after breast augmentation. Aesthet Plast Surg 2011; 35 (3): 315-318.

  25. Bumaschny E, Rafa CA, Reichman P. Evaluación preoperatoria del paciente quirúrgico. En: Galindo F y cols. Enciclopedia de cirugía digestiva. tomo I-101, 2013. pp. 1-20.

  26. Guía de referencia rápida. Diagnóstico y tratamiento de la infección aguda, no complicada del tracto urinario en la mujer. Guía de Práctica Clínica IMSS-077-08.

  27. López Tagle D, Hernández Ferrer M, Saldivar Arias T, Sotolongo Hernández T, Valdés Dupeyrón O. Infección de la herida quirúrgica: Aspectos epidemiológicos. Rev Cub Med Mil [Internet] 2007; 36 (2). Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S0138-65572007000200008&lng=es.

  28. Pineda V, Caceres J, Pernas JC, Catala J. Retromammary fluid collection as a late complication of breast implants: magnetic resonance imaging findings. J Comput Assist Tomogr 2004; 28: 386-389.

  29. Bengtson BP, Eaves FF III. High-resolution ultrasound in the detection of silicone gel breast implant shell failure: background, in vitro studies, and early clinical results. Aesthet Surg J 2012; 32: 157-174.

  30. Chung KC, Malay S, Shauver MJ, Kim HM. Economic analysis of screening strategies for rupture of silicone gel breast implants. Plast Reconstr Surg 2012; 130: 225-237.

  31. McCarthy CM, Pusic AL, Kerrigan CL. Silicone breast implants and magnetic resonance imaging screening for rupture: Do U.S. Food and Drug Administration recommendations reflect an evidence-based practice approach to patient care? Plast Reconstr Surg 2008; 121 (4): 1127-1134.

  32. Cuenca-Pardo J, Vélez-Benítez E, Ramos-Gallardo G, Iribarren-Moreno R. Seroma una alerta de patologías relacionadas a implantes mamarios MBE. Cir Plast 2019; 29 (1): 12-22.

  33. Ramos-Gallardo G, Carballo-Zarate AA, Cuenca-Pardo J, Cárdenas-Camarena L, Solano Genesta M, Beltrán JAC et al. What is the evidence of lymphoma in patients with prostheses other than breast implants? Aesthet Plast Surg 2020; 44 (2): 286-294.

  34. Palraj B, Paturi A, Stone RG, Alvarez H, Sebenik M, Perez MT et al. Soft tissue anaplastic large T-cell lymphoma associated with a metallic orthopedic implant: case report and review of the current literature. J Foot Ankle Surg 2010; 49: 561-564.

  35. Menter T, Ballova V, Caspar C, Wolff T, Kasend B, Singer G et al. ALK-negative anaplastic large cell lymphoma arising in the thrombus of an aortic prosthesis preceded by clonally related lymphomatoid papulosis. Virchows Archiv 2019; 474: 763-767.

  36. Suhail-Chaudhry M, Mather H, Marks A, Naresh K. Diffuse large B cell lymphoma complicating total knee arthroplasty: case report and literature review of the association of diffuse large B cell lymphoma with joint replacement. Acta Haematol 2011; 126: 141-146.

  37. Rajeev A, Ralte A, Choudhry N, Jabbar F, Banaszkiewicz P. Diffuse B cell non-Hodgkin's lymphoma presenting atypically as periprosthetic joint infection in a total hip replacement. Case Rep Orthop 2017; 2017: 7195016.

  38. McCarthy CL, Uchihara Y, Vlychou M, Grammatopoulos G, Athanasou NA. Development of malignant lymphoma after metal-on-metal hip replacement: a case report and review of the literature. Skeletal Radiol 2017; 46 (6): 831-836.

  39. Hallab NJ, Samelko L, Hammond D. The inflammatory effects of breast implant particulate shedding: comparison with orthopedic implants. Aesthet Surg J 2019; 39 (S1): 36-S48.

  40. Song JW, Kim HM, Bellfi LT, Chung KC. The effect of study design biases on the diagnostic accuracy of magnetic resonance imaging for detecting silicone breast implant ruptures: a meta-analysis. Plast Reconstr Surg 2011; 127: 1029-1044.

  41. Handel N, Garcia ME, Wixtrom R. Breast implant rupture: causes, incidence, clinical impact and management. Plast Reconstr Surg 2013; 132: 1128-1137.

  42. Gunawardana RT, Dessauvagie BF, Taylor DB. Breast implant-associated anaplastic large cell lymphoma, an under-recognized entity. J Med Imaging Radiat Oncol 2019; 63: 630-638.

  43. Leberfinger AN, Behar BJ, Williams NC, Rakszawski KL, Potochny JD, Mackay DR et al. Breast implant-associated anaplastic large cell lymphoma: a systematic review. JAMA Surg 2017; 152 (12): 1161-1168.

  44. Fitzal F, Turner SD, Kenner L. Is breast implant-associated anaplastic large cell lymphoma a hazard of breast implant surgery? Open Biol 2019; 9 (4): 190006. doi: 10.1098/rsob.190006.

  45. Clemens MW, Jacobsen ED, Horwitz SM. 2019 NCCN consensus guidelines on the diagnosis and treatment of breast implant-associated anaplastic large cell lymphoma (BIA-ALCL). Aesthet Surg J 2019; 39 (S1): S3-S13.

  46. Mazzocchi M, Dessy LA, Marchetti F, Marchetti F, Carlesimo B. The use of the Veress needle to drain mammary periprosthetic fluid. In Vivo 2010; 24: 219-222.

  47. Garcia-Tutor E, Murillo J. Safe drainage by puncture of post mastectomy seroma in a patient with immediate reconstruction using an expander. Plast Reconstr Surg 2003; 111: 1357-1358.

  48. Moyer KE, Potochny JD. Technique for seroma drainage in implant-based breast reconstruction. J Plast Reconstr Aesthet Surg 2012; 65: 1614-1617.

  49. Ramos-Gallardo G, Cuenca-Pardo J, Rodríguez-Olivares E, Iribarren-Moreno R, Contreras-Bulnes L, Vallarta-Rodríguez A et al. Breast implant and anaplastic large cell lymphoma meta-analysis. J Invest Surg 2017; 30: 56-65.

  50. Pinsolle V, Grinfeder C, Mathoulin-Pelissier S, Faucher A. Complications analysis of 266 immediate breast reconstructions. J Plast Reconstr Aesthet Surg 2006; 59: 1017-1024.

  51. Francis SH, Ruberg RL, Stevenson KB, Beck CE, Ruppert AS, Harper JT et al. Independent risk factors for infection in tissue expander breast reconstruction. Plast Reconstr Surg 2009; 124: 1790-1796.

  52. Nahabedian MY, Tsangaris T, Momen B, Manson P. Infectious complications following breast reconstruction with expanders and implants. Plast Reconstr Surg 2003; 112: 467-476.

  53. Rubino C, Brongo S, Pagliara D, Cuomo R, Abbinante G et al. Infections in breast implant: a review a focus and developing countries. J Infect Dev Ctries 2014; 8 (9): 1089-1095.

  54. Washer LL, Gutowski K. Breast implant infections. Infect Dis Clin N Am 2012; 26: 111-125.

  55. Cuenca-Pardo J, Ramos-Gallardo G, Contreras-Bulnes L, Iribarren-Moreno R, Rodríguez-Olivares E, Hernández-Valverde C et al. Factores relacionados con infecciones en implantes mamarios. Cir Plast 2015; 25 (1): 6-14.




2020     |     www.medigraphic.com